Delivery Order SPE2DB20D9127-SPE2DB25FPQN1

Award Date 5/9/25
Potential Completion Date 6/2/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,461.12, is for the supply of Stelara 130 mg/26 ml vials. The order falls under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to issue delivery orders for a comprehensive range of branded and generic...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $3,730.56 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Stelara 130 mg/26 ml vial. This delivery order is part of a larger indefinite delivery contract worth up to $4,999,999 that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical items to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,435.20, is for the delivery of the pharmaceutical product STELARA 130 MG/26 ML VIAL 26ML. This order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,217.60, is for the delivery of Stelara 130 mg/26 ml vials to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, for a...
This federal contract award was issued by the Defense Logistics Agency (DLA), under its Medical Supply Chain division, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,217.60 delivery order contract is for the supply of STELARA 130 MG/26 ML VIAL 26ML, a specialty pharmaceutical product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, under the SPE2DB program. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,212.00, is for the delivery of STELARA (ustekinumab) 130 mg/26 ml vials to support the recurring pharmaceutical needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,461.12 award is for the supply of 130 mg/26 ml vials of the drug Stelara, with a period of performance through December 6, 2024. This order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place delivery orders for a...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $4,974.08, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Stelara (130 mg/26 ml vial) to support the recurring medical supply needs of military health facilities. This delivery order was issued under a larger indefinite delivery contract (IDC) valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $98,648.16, is for the delivery of Stelara 90 mg/ml syringes. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 8, 2025. The contract does not have a set-aside designation. This award is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $57,544.76 firm fixed-price contract is for the delivery of Stelara 90 mg/ml syringes, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPQN1
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,574.76, is for the delivery of Stelara 130 mg/26 ml vials. This award is a delivery order under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 8/8/25, 9:48 AM